Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 11 | $2,415,312 |
Sells | 17 | $2,821,140 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
16 Sep 2024 17:12 | INBX | Inhibrx Biosciences Inc | LAPPE MARK | Chief Executive Officer | 16 Sep 2024 | Purchase | 13,037 | 17.13 | 223,324 | I |
16 Sep 2024 17:12 | INBX | Inhibrx Biosciences Inc | LAPPE MARK | Chief Executive Officer | 12 Sep 2024 | Purchase | 26,963 | 15.05 | 405,793 | I |
10 Sep 2024 17:00 | INBX | Inhibrx Biosciences Inc | LAPPE MARK | Chief Executive Officer | 10 Sep 2024 | Purchase | 8,500 | 15.19 | 129,115 | I |
10 Sep 2024 17:00 | INBX | Inhibrx Biosciences Inc | LAPPE MARK | Chief Executive Officer | 09 Sep 2024 | Purchase | 9,500 | 15.21 | 144,495 | I |
10 Sep 2024 17:00 | INBX | Inhibrx Biosciences Inc | LAPPE MARK | Chief Executive Officer | 06 Sep 2024 | Purchase | 26,000 | 15.29 | 397,540 | I |
03 Sep 2024 17:31 | INBX | Inhibrx Biosciences Inc | LAPPE MARK | Chief Executive Officer | 03 Sep 2024 | Purchase | 4,712 | 16.31 | 76,853 | I |
03 Sep 2024 17:31 | INBX | Inhibrx Biosciences Inc | LAPPE MARK | Chief Executive Officer | 03 Sep 2024 | Purchase | 15,288 | 15.66 | 239,410 | I |
03 Sep 2024 17:31 | INBX | Inhibrx Biosciences Inc | LAPPE MARK | Chief Executive Officer | 30 Aug 2024 | Purchase | 10,000 | 14.02 | 140,200 | I |
03 Sep 2024 17:31 | INBX | Inhibrx Biosciences Inc | LAPPE MARK | Chief Executive Officer | 29 Aug 2024 | Purchase | 10,000 | 14.03 | 140,300 | I |
22 Aug 2024 16:29 | INBX | Inhibrx Biosciences Inc | LAPPE MARK | Chief Executive Officer | 21 Aug 2024 | Purchase | 12,945 | 12.93 | 167,379 | I |
22 Aug 2024 16:29 | INBX | Inhibrx Biosciences Inc | LAPPE MARK | Chief Executive Officer | 20 Aug 2024 | Purchase | 27,055 | 12.97 | 350,903 | I |
01 Mar 2023 16:41 | INBX | Inhibrx Inc | LAPPE MARK | Chief Executive Officer | 28 Feb 2023 | Sale | 60 | 25.0208 | 1,501 | I |
24 Jan 2023 18:46 | INBX | Inhibrx Inc | LAPPE MARK | Chief Executive Officer | 24 Jan 2023 | Sale | 63 | 26.1127 | 1,645 | I |
24 Jan 2023 18:46 | INBX | Inhibrx Inc | LAPPE MARK | Chief Executive Officer | 24 Jan 2023 | Sale | 4,272 | 25.71 | 109,833 | I |
24 Jan 2023 18:46 | INBX | Inhibrx Inc | LAPPE MARK | Chief Executive Officer | 23 Jan 2023 | Sale | 21,665 | 25.3572 | 549,364 | I |
20 Dec 2022 16:59 | INBX | Inhibrx Inc | LAPPE MARK | Chief Executive Officer | 19 Dec 2022 | Sale | 754 | 26.2859 | 19,820 | I |
20 Dec 2022 16:59 | INBX | Inhibrx Inc | LAPPE MARK | Chief Executive Officer | 19 Dec 2022 | Sale | 25,246 | 25.5337 | 644,624 | I |
18 Nov 2022 17:06 | INBX | Inhibrx Inc | LAPPE MARK | Chief Executive Officer | 17 Nov 2022 | Sale | 1,150 | 32.3837 | 37,241 | I |
18 Nov 2022 17:06 | INBX | Inhibrx Inc | LAPPE MARK | Chief Executive Officer | 17 Nov 2022 | Sale | 912 | 30.668 | 27,969 | I |
18 Nov 2022 17:06 | INBX | Inhibrx Inc | LAPPE MARK | Chief Executive Officer | 17 Nov 2022 | Sale | 6,773 | 30.1485 | 204,196 | I |
18 Nov 2022 17:06 | INBX | Inhibrx Inc | LAPPE MARK | Chief Executive Officer | 17 Nov 2022 | Sale | 1,767 | 28.8574 | 50,991 | I |
18 Nov 2022 17:06 | INBX | Inhibrx Inc | LAPPE MARK | Chief Executive Officer | 17 Nov 2022 | Sale | 4,333 | 27.4492 | 118,937 | I |
18 Nov 2022 17:06 | INBX | Inhibrx Inc | LAPPE MARK | Chief Executive Officer | 17 Nov 2022 | Sale | 4,106 | 26.5703 | 109,098 | I |
18 Nov 2022 17:06 | INBX | Inhibrx Inc | LAPPE MARK | Chief Executive Officer | 17 Nov 2022 | Sale | 6,959 | 25.3596 | 176,477 | I |
18 Oct 2022 16:37 | INBX | Inhibrx Inc | LAPPE MARK | Chief Executive Officer | 17 Oct 2022 | Sale | 121 | 31.5071 | 3,812 | I |
18 Oct 2022 16:37 | INBX | Inhibrx Inc | LAPPE MARK | Chief Executive Officer | 17 Oct 2022 | Sale | 2,892 | 30.8055 | 89,090 | I |
18 Oct 2022 16:37 | INBX | Inhibrx Inc | LAPPE MARK | Chief Executive Officer | 17 Oct 2022 | Sale | 14,006 | 29.9245 | 419,123 | I |
18 Oct 2022 16:37 | INBX | Inhibrx Inc | LAPPE MARK | Chief Executive Officer | 17 Oct 2022 | Sale | 8,981 | 28.6626 | 257,419 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)